|
SSX2IP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.15590000000043E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.77429999999435E-05 |
| Normal-vs-Stage2 |
2.244100E-03 |
| Normal-vs-Stage3 |
2.639200E-04 |
| Normal-vs-Stage4 |
1.51172999999227E-05 |
| Stage1-vs-Stage2 |
6.945400E-01 |
| Stage1-vs-Stage3 |
8.375800E-01 |
| Stage1-vs-Stage4 |
2.030600E-01 |
| Stage2-vs-Stage3 |
7.971200E-01 |
| Stage2-vs-Stage4 |
6.718000E-01 |
| Stage3-vs-Stage4 |
3.616200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.85100000000316E-05 |
| Normal-vs-AfricanAmerican |
7.907800E-02 |
| Normal-vs-Asian |
1.583590E-04 |
| Caucasian-vs-AfricanAmerican |
3.754800E-01 |
| Caucasian-vs-Asian |
5.883200E-01 |
| AfricanAmerican-vs-Asian |
2.317800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.60820000042017E-08 |
| Normal-vs-Female |
3.835700E-04 |
| Male-vs-Female |
5.175800E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.181570E-04 |
| Normal-vs-Age(41-60Yrs) |
6.21650000000029E-05 |
| Normal-vs-Age(61-80Yrs) |
3.371000E-04 |
| Normal-vs-Age(81-100Yrs) |
5.157400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.130600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.891000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.945000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.533600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.111800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.960000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.118800E-01 |
| Classical-VS-Follicular |
1.6567999999717E-06 |
| Classical-VS-Other |
1.099790E-01 |
| Classical-VS-Normal |
2.276900E-03 |
| Tall-VS-Follicular |
1.132040E-02 |
| Tall-VS-Other |
1.665570E-01 |
| Tall-VS-Normal |
1.134230E-02 |
| Follicular-VS-Other |
9.500800E-01 |
| Follicular-VS-Normal |
1.76309999933011E-09 |
| Other-VS-Normal |
5.040600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.71904999999306E-05 |
| Normal-vs-N1 |
1.73260000002617E-06 |
| N0-vs-N1 |
3.947000E-01 |
|
|
